Cutaneous T Cell Lymphoma
Showing 1 - 22 of 22
Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
Not yet recruiting
- Cutaneous T Cell Lymphoma
- +2 more
-
Ancona, Italy
- +19 more
Nov 2, 2023
Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Fungoides Mycosis Sezary Syndrome
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Jul 13, 2023
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- Hypericin
- Visible Light
- (no location specified)
May 23, 2023
Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)
Recruiting
- Advanced Solid Tumor
- Cutaneous T Cell Lymphoma
-
Guanzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Mar 10, 2023
Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))
Not yet recruiting
- Cutaneous T Cell Lymphoma
- APR-TD011 (RLF-TD011)
-
Chicago, IllinoisDermatology CTU
Feb 6, 2023
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the
Recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
- THERAKOS® CELLEX photopheresis system
-
New York, New YorkHerbert Irving Pavilion
Dec 23, 2022
Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)
Active, not recruiting
- Advanced Cancer
- +16 more
-
Scottsdale, Arizona
- +3 more
Dec 22, 2022
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)
Not yet recruiting
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
- Mogamulizumab
- Brentuximab vedotin
- (no location specified)
Dec 7, 2022
Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care
Recruiting
- Cutaneous T Cell Lymphoma
- Peripheral T Cell Lymphoma
- Microdevices
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 16, 2022
Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))
Recruiting
- Cutaneous T Cell Lymphoma
- Micro needle array-Doxorubicin (MNA-D)
-
Pittsburgh, PennsylvaniaUniversity Of Pittsburgh Medical Center
Jun 2, 2022
Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)
Completed
- Cutaneous T Cell Lymphoma
- +2 more
-
Leeds, United KingdomCovance Clinical research Unit Ltd.
Feb 3, 2022
Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)
Not yet recruiting
- Mycosis Fungoides
- Cutaneous T Cell Lymphoma
- Low-dose total-skin electron-beam therapy
- Phototherapy
- (no location specified)
Jan 24, 2022
Characterization of the Microbiome in Cutaneous T Cell Lymphoma
Recruiting
- Cutaneous T Cell Lymphoma
-
Chicago, IllinoisNorthwestern University
Oct 2, 2021
Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With
Active, not recruiting
- Cutaneous T Cell Lymphoma
- Graft Versus Host Disease
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Aug 31, 2021
Cutaneous T Cell Lymphoma Trial in Mannheim (dimethylfumarate)
Unknown status
- Cutaneous T Cell Lymphoma
-
Mannheim, GermanyUniversity Medical Center
Sep 30, 2019
STAT3 in T Cells: At The Crossroads of Inflammation and Cancer
Terminated
- Cutaneous T Cell Lymphoma
-
New York, New YorkNYU Langone Medical Center
Sep 13, 2018
Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in United States (Methoxsalen+ECP)
Completed
- Cutaneous T Cell Lymphoma
- Mycosis Fungoides
-
Chicago, Illinois
- +6 more
Aug 15, 2018
Psoriasis, Cutaneous T Cell Lymphoma, Lymphoproliferative Disorders Trial in Graz (Photo(chemo)therapy)
Recruiting
- Psoriasis
- +10 more
- Photo(chemo)therapy
-
Graz, Styria, AustriaMedical University of Graz, Department of Dermatology
Nov 7, 2017
Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)
Completed
- Cutaneous T Cell Lymphoma
- Peripheral T Cell Lymphoma
-
Scottsdale, Arizona
- +12 more
Apr 13, 2017
Cutaneous T Cell Lymphoma Trial in Paris (Blood sampling)
Unknown status
- Cutaneous T Cell Lymphoma
- Blood sampling
-
Paris, FranceSaint Louis hospital
Apr 15, 2016
Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma Trial
Completed
- Peripheral T Cell Lymphoma Unspecified
- +3 more
- RAD001 (Everolimus)
-
Goyang-si, Kyoungki-do, Korea, Republic of
- +4 more
Mar 1, 2015